Jeffrey R. Sachs

Merck & Co., Inc., Rahway, NJ, USA (United States)

MedicineComputer ScienceMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical Trial”.

Immunogenicity and Safety of a Tetravalent Recombinant Subunit Dengue Vaccine in Adults Previously Vaccinated with a Live Attenuated Tetravalent Dengue Vaccine: Results of a Phase-I Randomized Clinical Trial

American Journal of Tropical Medicine and Hygiene(2020)10.4269/ajtmh.20-0042

N/A

0.895DataRank · unranked

27 citations

Kristen K. Pierce, Beth D. Kirkpatrick, Palmtama L. Grier, Beulah P. Sabundayo, Helen He +11 more